This trial is testing whether adding stem cells to rotator cuff surgery helps the repair better than surgery alone. 100 patients will be followed for at least a year.
1 Primary · 3 Secondary · Reporting Duration: 1 year
Experimental Treatment
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: Mesenchymal stem cell augmentation in rotator cuff repair · Has Placebo Group · N/A
Age 18 - 70 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: